Lhasa Limited

Lhasa Limited

Software Development

Leeds, West Yorkshire 7,987 followers

Supporting informed decision making on chemical safety across the life sciences industry.

About us

At Lhasa, we are driven by our purpose; To enable informed decision making on chemical safety. As a not-for-profit organisation and educational charity, we create cutting-edge software technology which streamlines compound development and minimises animal testing. Our technology is designed by scientists, for scientists, in collaboration with industry stakeholders and regulators. Learn more about how we can support your chemical safety assessments: https://ow.ly/l8kL50Q79w4. Based in Leeds, we provide hybrid and flexible work options, priding ourselves on our strong sense of connection, inclusivity, and support. We are committed to creating an environment where our colleagues feel comfortable to be themselves and feel empowered. By encouraging and embracing diversity and inclusivity, we experience better discussions, decisions, and outcomes. Would you like to be part of our future? Discover more about life at Lhasa and view our current opportunities: https://ow.ly/fNZf50Q79MG.

Industry
Software Development
Company size
51-200 employees
Headquarters
Leeds, West Yorkshire
Type
Nonprofit
Founded
1983
Specialties
Software, in silico prediction systems, databases, toxicity, chemistry, life sciences, ICH M7, and collaboration

Locations

  • Primary

    Granary Wharf House

    2 Canal Wharf

    Leeds, West Yorkshire LS11 5PS, GB

    Get directions

Employees at Lhasa Limited

Updates

  • View organization page for Lhasa Limited, graphic

    7,987 followers

    Join our webinar in #Spanish, discussing API safety through effective impurity and degradant management under ICH M7! 💊 📅 28 November 🕙 10:00 - 12:00 COT / 12:00 - 14:00 ART / 16:00 - 18:00 CEST 🗣️ Spanish 🔗 https://buff.ly/3Umwgzn Lucía Toscano Bayona, Application Scientist at Lhasa Limited ➡ Lucia will showcase how Zeneth predicts degradation pathways and aids in identifying potential impurities, streamlining #API risk assessment and degradation product characterisation. Dr Maria Celeste del Fueyo, PhD, Application Scientist at Lhasa Limited ➡ Celeste will highlight how Derek Nexus (expert knowledge-based) and Sarah Nexus (statistical-based) provide robust (Q)SAR assessments, predicting mutagenic and carcinogenic potential for comprehensive ICH M7 risk evaluation. Dr Mariana Mendez, Manager of Bioanalytical Development and Genotoxic Impurities at Baliarda S.A. ➡ Mariana will share insights into how Baliarda conduct #ICHM7 risk assessment through a real-world case study on an API. Register now: https://buff.ly/3Umwgzn #Webinar #Pharmaceutical

    • No alternative text description for this image
    • No alternative text description for this image
  • Lhasa Limited reposted this

    View organization page for Lhasa Limited, graphic

    7,987 followers

    We are delighted to be taking part in an online seminar and panel discussion with Thermo Fisher Scientific! Join this panel of experts as they examine the challenge of NDSRI analysis including matrix effects, and the risk of false positive results arising during sample preparation. 💻 29th October, 12pm (EDT) / 4pm (GMT) Join our Senior Global Alliances Manager Grace Kocks, as the panel present and discuss: 🔹 Nitrites in excipients 🔹 Nitrite and NDSRI analysis methods and challenges 🔹 NDSRI risk assessment 🔹 The industry accessible NDSRI database hosted by Lhasa Limited Sign up to the webinar here: https://buff.ly/3YicE0H

    • No alternative text description for this image
  • View organization page for Lhasa Limited, graphic

    7,987 followers

    We're excited to participate in the American College of Toxicology (ACT) 2024 annual convention in Austin, Texas next month! Our Senior Application Scientist, Dr Charlie Modlin, will be leading an industry hosted session discussing: 𝗦𝗲𝘁𝘁𝗶𝗻𝗴 𝗹𝗶𝗺𝗶𝘁𝘀 𝗳𝗼𝗿 𝗻𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗼𝘁𝗵𝗲𝗿 𝗶𝗺𝗽𝘂𝗿𝗶𝘁𝘆 𝗰𝗹𝗮𝘀𝘀𝗲𝘀 𝘂𝘀𝗶𝗻𝗴 𝗶𝗻 𝘀𝗶𝗹𝗶𝗰𝗼 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀, 𝗶𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗴 𝗿𝗲𝗮𝗱-𝗮𝗰𝗿𝗼𝘀𝘀 On Tuesday 19th November from 12:00 – 12:55, learn how the Lhasa carcinogenic potency categorisation approach (CPCA) tool can enhance your impurity assessment, and how to determine compound-relevant limits for these impurity types using an in silico read-across workflow. We will also be exhibiting at the meeting in Booth 313 – so if you're attending, we can’t wait to see you there! Find out more: https://buff.ly/4f8F3Nd

    • No alternative text description for this image
  • View organization page for Lhasa Limited, graphic

    7,987 followers

    Dive into our latest #blog where we tackle 10 frequently asked questions about Mirabilis. 🔍 Identification and control of impurities in active pharmaceutical ingredients (APIs) and pharmaceutical drug products is critical in drug development. Mirabilis is our innovative solution designed to address this challenge. In this post, we’ll answer ten frequently asked questions! https://buff.ly/485nqMd #InSilico #DrugDevelopment #PMIs #Mutagenic #Impurities #ICHM7

    • No alternative text description for this image
  • View organization page for Lhasa Limited, graphic

    7,987 followers

    Great to see a full house at our Lhasa symposium in Seoul, South Korea, alongside BITEK CHEMS. 💙

    View profile for Crina Heghes, graphic

    Director of Applied Sciences at Lhasa Limited| CEO at Consult Lhasa

    The long awaited day for Lhasa Limited and Bitek Chems Inc. symposium in Seoul, opened by our CEO Chris Barber and Gabriela Silveira with the first presentation on ICH M7 tox assessment use cases. Great to see the full house again and connect with our members in the pharma industry in South Korea!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Lhasa Limited reposted this

    View profile for David Ponting, graphic

    Principal Scientist at Lhasa Limited | Lead Scientific Consultant at Consult Lhasa

    It’s been a pleasure to present on Lhasa Limited’s new #readacross tool Acrostic in the Lhasa Limited/Bitek Chems symposium in Seoul just now - I even took advantage of some of the hills surrounding this bustling city to collect extra supporting evidence for the mountaineering analogy… If you haven’t heard this, you’re missing out, so get in touch via https://lnkd.in/eK9SSmBD to find out more about Acrostic and how we can support your #chemicalsafety decisions, for #nitrosamines and beyond!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +3
  • Lhasa Limited reposted this

    View profile for Nayza Fioritta Neves Ferro, graphic

    Head of IT at Lhasa Limited & Consult Lhasa

    What a day, what a team! 😍 Last week our Lhasa Limited IT team came together for an incredible team building day that was both fun and productive. We started with a unique 'washing instructions' activity, which gave us the opportunity to understand how our colleagues prefer to work, their expectations, get to know each other better and build empathy and respect for our differences. Following that, we had a productive IT360 brainstorming session where we identified gaps and opportunities based on our core pillars: IT as one team, user experience, security by design, member confidence, resilience, and robustness. To wrap up the day, we enjoyed a fun and highly competitive pub quiz, which brought out the best in everyone and strengthened our team spirit. Feeling grateful for such a dedicated and collaborative team. 🚀 And of course, we couldn't end the day without our traditional photo in front of the blue door. 📸 #informationtechnology #collaboration #teambuilding #diversity

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Lhasa Limited, graphic

    7,987 followers

    We are delighted to be taking part in an online seminar and panel discussion with Thermo Fisher Scientific! Join this panel of experts as they examine the challenge of NDSRI analysis including matrix effects, and the risk of false positive results arising during sample preparation. 💻 29th October, 12pm (EDT) / 4pm (GMT) Join our Senior Global Alliances Manager Grace Kocks, as the panel present and discuss: 🔹 Nitrites in excipients 🔹 Nitrite and NDSRI analysis methods and challenges 🔹 NDSRI risk assessment 🔹 The industry accessible NDSRI database hosted by Lhasa Limited Sign up to the webinar here: https://buff.ly/3YicE0H

    • No alternative text description for this image

Similar pages

Browse jobs